Clorox CO /DE/ 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Clorox completes the $2.25 billion acquisition of GOJO Industries and buys out P&G's stake in the Glad business while navigating a flat sales quarter.
NYSE
Clorox reports a decline in Q2 net earnings and diluted EPS, driven by lower sales and higher costs, while announcing the strategic acquisition of GOJO Industries for $2.25 billion.
NYSE
Clorox reports a significant 19% drop in net sales and diluted EPS for Q1 FY26, primarily due to ERP system transition impacts and ongoing macroeconomic pressures.
NYSE
Clorox's Q3 2025 results show a decrease in net sales due to divestitures, but a significant increase in earnings driven by margin expansion and cost savings.
NYSE
Clorox's second quarter of fiscal year 2025 saw a decrease in net sales but an increase in earnings per share, influenced by divestitures, cyberattack recovery, and cost-saving measures.
NYSE
Clorox's first quarter of fiscal year 2025 shows significant improvement in sales and earnings, primarily due to recovery from a prior cyberattack and strategic divestitures.
NYSE
Clorox's Q3 results show a net loss, impacted by a cyberattack and divestiture, but gross margins improved due to pricing and cost savings.
NYSE
Clorox updates its executive retirement plan and releases its second quarter 2024 financial results, showing recovery from a cyberattack while navigating a complex economic environment.